Mina Yeganeh

15 statements · 1 topic · summaries given as host listed separately

Featured statements

▶ Ep 20 · 1:00
necrotizing enterocolitis, or neck is a devastating gastrointestinal disease in neonates. It starts with severe intestinal inflammation, which can lead to intestinal necrosis and perforation and ultimately multi-system organ failure.
▶ Ep 20 · 4:10
Fluorescently tagged microRNA-148a was present in the cytosol of intestinal epithelial cells after LNP administration via enema in healthy neonatal mice, demonstrating successful delivery.

Nothing matches these filters — clear the search or widen the filters.

Mina's statements about Necrotizing Enterocolitis 15 statements

Open the Necrotizing Enterocolitis collection →

Mina Yeganeh, BSc - Best of the Best in Pediatric Surgery 2024

▶ Ep 20 · 0:41
clinical Necrotizing enterocolitis starts with severe intestinal inflammation, which can lead to intestinal necrosis and perforation and ultimately multi-system organ failure. ↗
▶ Ep 20 · 1:00
quote necrotizing enterocolitis, or neck is a devastating gastrointestinal disease in neonates. It starts with severe intestinal inflammation, which can lead to intestinal necrosis and perforation and ultimately multi-system organ failure. ↗
▶ Ep 20 · 1:55
quote Despite these protective effects, the underlying mechanisms of milk EVs remain unclear, preventing their clinical translation. ↗
▶ Ep 20 · 2:00
clinical MicroRNA-148a is the most abundant microRNA in milk extracellular vesicles. ↗
▶ Ep 20 · 2:45
clinical TLR-4 is a pattern recognition receptor that is critical for the initiation of inflammatory response. ↗
▶ Ep 20 · 4:00
clinical Lipid nanoparticles encapsulate nucleic acids and release them inside cells in a pH responsive manner. ↗
▶ Ep 20 · 4:10
clinical Fluorescently tagged microRNA-148a was present in the cytosol of intestinal epithelial cells after LNP administration via enema in healthy neonatal mice, demonstrating successful delivery. ↗
▶ Ep 20 · 4:30
clinical Administration of microRNA-148a and TLR-4 siRNA antagonist both significantly reduced intestinal injury in experimental NEC compared to untreated NEC mice. ↗
▶ Ep 20 · 4:45
clinical NEC results in significant increase in gene expression of pro-inflammatory cytokines TNF-α and IL-6 in the intestine compared to control mice. ↗
▶ Ep 20 · 5:00
clinical Administration of microRNA-148a and TLR-4 antagonists both result in significantly lower inflammation (reduced TNF-α and IL-6 expression) in the intestine during experimental NEC. ↗
▶ Ep 20 · 5:15
clinical NF-κB is a transcription factor downstream of TLR-4. ↗
▶ Ep 20 · 5:20
clinical Lipopolysaccharide activates the Toll-like receptor pathway and causes significant rise in NF-κB expression. ↗
▶ Ep 20 · 5:28
clinical MicroRNA-148a and TLR-4 antagonist both significantly lower NF-κB expression at two different concentrations when administered with LPS. ↗
▶ Ep 20 · 5:54
clinical In the experimental NEC model used (P5 to P9), the surge in intestinal injury and inflammation occurs around P6 and increases from P6 to P7. ↗
▶ Ep 20 · 5:54
quote it's really hard to distinguish between preventative and therapeutic, uh, interventions with the, uh, experimental model that we have right now for neck. ↗

Summaries Mina gave as host · 4 summaries

Recaps of other experts' statements, not Mina's own clinical position.

Summaries Mina gave as host · Necrotizing Enterocolitis 4 summaries

Open the Necrotizing Enterocolitis collection →

Mina Yeganeh, BSc - Best of the Best in Pediatric Surgery 2024

▶ Ep 20 · 1:30
host summary Mina Yeganeh summarizing a resource: Administration of human milk extracellular vesicles protects mice from developing NEC, with significantly lower intestinal injury scores and lower intestinal inflammation compared to untreated NEC. ↗
▶ Ep 20 · 2:20
host summary Mina Yeganeh summarizing a resource: MicroRNA-148a has shown to reduce the inflammatory response in other disease models. ↗
▶ Ep 20 · 2:30
host summary Mina Yeganeh summarizing a resource: The anti-inflammatory effect of microRNA-148a is mainly through the inhibition of Toll-like receptor 4 (TLR-4) pathway. ↗
▶ Ep 20 · 2:55
host summary Mina Yeganeh summarizing a resource: Dr. David Hackam's group has shown that TLR-4 signaling is required for the development of experimental NEC. ↗